QSAR Modeling of SARS‐CoV Mpro Inhibitors Identifies Sufugolix, Cenicriviroc, Proglumetacin, and other Drugs as Candidates for Repurposing against SARS …; Multi-descriptor read across (MuDRA): A simple and transparent approach for developing accurate quantitative structure–activity relationship models; Learning from history: do not flatten the curve of antiviral research!; Biolink Model: A universal schema for knowledge graphs in clinical, biomedical, and translational science; STopTox: An in Silico Alternative to Animal Testing for Acute Systemic and Topical Toxicity; SCAM detective: accurate predictor of small, colloidally aggregating molecules; Computational models identify several FDA approved or experimental drugs as putative agents against SARS-CoV-2; COVID-KOP: integrating emerging COVID-19 data with the ROBOKOP database; Knowledge-based approaches to drug discovery for rare diseases; Progress toward a universal biomedical data translator; Defining clinical outcome pathways; STopTox: An in-silico alternative to animal testing for acute Systemic and TOPical TOXicity; Compact walks: Taming knowledge-graph embeddings with domain-and task-specific pathways; ZINC Express: a virtual assistant for purchasing compounds annotated in the zinc database; COVID-19 Knowledge Extractor (COKE): A Curated Repository of Drug–Target Associations Extracted from the CORD-19 Corpus of Scientific Publications on COVID-19; User-Interfaces for Incremental Recipient and Response Time Predictions in Asynchronous Messaging; PreS/MD: Predictor of sensitization hazard for chemical substances released from medical devices; Small Molecule Antiviral Compound Collection (SMACC): a database to support the discovery of broad-spectrum antiviral drug molecules; COVID-19 Knowledge Extractor (COKE): a tool and a web portal to extract drug-target protein associations from the CORD-19 corpus of scientific publications on COVID-19; In silico platform as an alternative to animal testing for acute toxicity
